Key Resources: Buprenorphine Treatment for Opioid Addiction

Citations from Key Results

Auriacombe, M., M. Fatseas, et al. (2004). "French Field Experience with Buprenorphine." American Journal on Addictions 13: S17-S28.

Barnett, P. G., G. S. Zaric, et al. (2001). "The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States." Addiction 96(9): 1267-78.

Barnett, P. G., J. H. Rodgers, et al. (2001). "A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence." Addiction 96(5): 683-90.

Bickel, W. K., M. L. Stitzer, et al. (1988). "A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts." Clin Pharmacol Ther 43(1): 72-8.

Center for Substance Abuse Treatment (2005). Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Substance Abuse and Mental Health Services Administration.

Cicero, T. J. and J. A. Inciardi (2005). "Potential for abuse of buprenorphine in office-based treatment of opioid dependence." New England Journal of Medicine 353(17): 1863-5.

Comer, S. D., M. A. Sullivan, et al. (2005). "Comparison of Intravenous Buprenorphine and Methadone Self-Administration by Recently Detoxified Heroin-Dependent Individuals." J Pharmacol Exp Ther 315(3): 1320-1330.

Connock, M., A. Juarez-Garcia, et al. (2007). "Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation." Health Technol Assess 11(9): 1-171, iii-iv.

Doran, C. M., M. Shanahan, et al. (2003). "Buprenorphine versus methadone maintenance: a cost-effectiveness analysis." Drug & Alcohol Dependence 71(3): 295-302.

Ducharme , L.J. and A.J. Abraham (2008). State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse Treatment, Prevention and Policy 3(17): 1-10.

Fanoe, S., C. Hvidt, et al. (2007). "Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen." Heart 93(9): 1051-1055.

Fiellin, D. A. (2007). "The First Three Years of Buprenorphine in the United States: Experience to Date and Future Directions." Journal of Addiction Medicine 1(2): 62-67.

Fiellin, D. A. and P. G. O'Connor (2002). "New federal initiatives to enhance the medical treatment of opioid dependence." Annals of Internal Medicine 137(8): 688-92.

Fiellin, D. A., R. A. Rosenheck, et al. (2001). "Office-Based Treatment for Opioid Dependence: Reaching New Patient Populations." Am J Psychiatry 158(8): 1200-1204.

Fischer, G., W. Gombas, et al. (1999). "Buprenorphine versus methadone maintenance for the treatment of opioid dependence." Addiction 94(9): 1337-1347.

Fudala, P. J., T. P. Bridge, et al. (2003). "Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone." New England Journal of Medicine 349(10): 949-58.

Geib, A.-J., K. Babu, et al. (2006). "Adverse Effects in Children After Unintentional Buprenorphine Exposure." Pediatrics 118(4): 1746-1751.

Gowing, L., R. Ali, et al. (2004). "Buprenorphine for the management of opioid withdrawal.[update of Cochrane Database Syst Rev. 2002;(2):CD002025; PMID: 12076434]." Cochrane Database of Systematic Reviews(4): CD002025.

Harris, A. H., E. Gospodarevskaya, et al. (2005). "A Randomised Trial of the Cost Effectiveness of Buprenorphine as an Alternative to Methadone Maintenance Treatment for Heroin Dependence in a Primary Care Setting." PharmacoEconomics 23(1): 77-91.

Horgan, C. M., S. Reif, et al. (2008). "Availability of addiction medications in private health plans." Journal of Substance Abuse Treatment 34(2): 147-156.

Johnson, R. E., J. H. Jaffe, et al. (1992). "A controlled trial of buprenorphine treatment for opioid dependence." JAMA 267(20): 2750-5.

Johnson, R. E., T. Eissenberg, et al. (1995). "A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence." Drug & Alcohol Dependence 40(1): 17-25.

Kleber, H.D. (2008). "Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA 300 (19): 2303-2305.

Kosten, T. R., R. Schottenfeld, et al. (1993). "Buprenorphine versus methadone maintenance for opioid dependence." J Nerv Ment Dis 181(6): 358-64.

Kuehn, B. M. (2005). "Office-Based Treatment for Opioid Addiction Achieving Goals." JAMA 294(7): 784-786.

Ling, W., D. Wesson, et al. (1996). "A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence." Arch Gen Psychiatry 53(5): 401-7.

Magura, S., S. Lee, et al. (2007). "Outcomes of buprenorphine maintenance in office-based practice." Journal of Addictive Diseases 26(2): 13-23.

Mark, T. L., G. E. Woody, et al. (2001). "The economic costs of heroin addiction in the United States." Drug and Alcohol Dependence 61(2): 195-206.

Mattick, R. P., J. Kimber, et al. (2004). "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.[update of Cochrane Database Syst Rev. 2003;(2):CD002207; PMID: 12804429]." Cochrane Database of Systematic Reviews(3): CD002207.

McCance-Katz, E., D. Moody, et al. (2006a). "Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine." Clinical Infectious Diseases 43(s4): S224-S234.

McCance-Katz, E., D. Moody, et al. (2006b). "Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir." Clinical Infectious Diseases 43(s4): S235-S246.

McCarty, D., R. G. Frank, et al. (1999). "Methadone Maintenance and State Medicaid Managed Care Programs." The Milbank Quarterly 77(3): 341-362.

Mintzer, I. L., M. Eisenberg, et al. (2007). "Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings." Ann Fam Med 5(2): 146-150.

Moore, B., D. Fiellin, et al. (2007). "Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients." Journal of General Internal Medicine 22(4): 527-530.

National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction (1998). "Effective medical treatment of opiate addiction." JAMA 280(22): 1936-43.

Netherland, J.M., M. Botsko, et al. (2008). "Factors affecting willingness to provide buprenorphine treatment." Journal of Substance Abuse Treatment 36(3): 244-251.

O'Connor, P. G., A. H. Oliveto, et al. (1996). "A pilot study of primary-care-based buprenorphine maintenance for heroin dependence." American Journal of Drug & Alcohol Abuse 22(4): 523-31.

O'Connor, P. G., A. H. Oliveto, et al. (1998). "A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic." American Journal of Medicine 105(2): 100-5.

Petitjean, S., R. Stohler, et al. (2001). "Double-blind randomized trial of buprenorphine and methadone in opiate dependence." Drug & Alcohol Dependence 62(1): 97-104.

Rosenheck, R. and T. Kosten (2001). "Buprenorphine for opiate addiction: potential economic impact." Drug and Alcohol Dependence 63(3): 253-262.

Schackman, B. R., J. O. Merrill, et al. (2006). "Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care." Clinical Infectious Diseases 43 Suppl 4: S247-53.

Schottenfeld, R. S., J. R. Pakes, et al. (1997). "Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse." Arch Gen Psychiatry 54(8): 713-20.

Schulte, F. and D. Donovan. (2007, December 16). "The ‘bupe’ fix." 2008, from http://www.baltimoresun.com/news/health/bal-te.bupe16dec16,0,4702464.story.

Sporer, K. A. (2004). "Buprenorphine: A primer for emergency physicians." Annals of Emergency Medicine 43(5): 580-584.

Stein, M. D., P. Cioe, et al. (2005). "Buprenorphine retention in primary care." Journal of General Internal Medicine 20(11): 1038-41.

Strain, E. C., M. L. Stitzer, et al. (1994). "Comparison of buprenorphine and methadone in the treatment of opioid dependence." American Journal of Psychiatry 151(7): 1025-30.

Substance Abuse and Mental Health Services Administration. (2006). "Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators. Final Report." Retrieved May 25, 2008, 2008, from http://buprenorphine.samhsa.gov/Buprenorphine_FinalReport_12.6.06.pdf.

Substance Abuse and Mental Health Services Administration. (2006a). "The SAMHSA Evaluation of the Impact of the DATA Waiver Program, Summary Report." from

Substance Abuse and Mental Health Services Administration. (2006b). "Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators. Results of the Vermont Case Study." Retrieved May 25, 2008, 2008, from http://buprenorphine.samhsa.gov/Vermont.Case.Study_12.5.06.pdf.

Sullivan, L. E., M. Chawarski, et al. (2005). "The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?" Drug and Alcohol Dependence 79(1): 113.

Thomas, C.P., S. Reif, et al. (2008). Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatric Services 59(8): 909-916.

Walley, A.Y., J.K. Alperen, et al. (2008). Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Journal of General Internal Medicine 23(9): 1393-1398.

Walsh, S. L., K. L. Preston, et al. (1994). "Clinical pharmacology of buprenorphine: ceiling effects at high doses." Clin Pharmacol Ther 55(5): 569-80.

West, S. L., K. K. O'Neal, et al. (2000). "A meta-analysis comparing the effectiveness of buprenorphine and methadone." Journal of Substance Abuse 12(4): 405-414.